Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Tranilast

An antiallergic derived from anthranilic acid, approved in 1982 in Japan and South Korea for bronchial asthma and, later in the 1980s, also for keloids and hypertrophic scars. This family brings together the active ingredient and other impurities.

Did you know?It is an analogue of a tryptophan metabolite; it has also been studied because it blocks the NLRP3 inflammasome, a cellular 'sensor' that triggers inflammation.

TranilastGo to the active ingredient →
TranilastActive ingredientTranilastCat. No. P-T177-001CAS 53902-12-8

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.